Selumetinib |
Selumetinib : Covalent, ATP noncompetitive inhibitor of MAP2K1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MAP2K1 |
|
|
Covalent Inhibitor
10 nM - 200 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
No activity was detected with 10 uM Selumetinib against 40 kinases.
Potency Cellular
In Vitro
MAP2K1
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1158/1078-0432.CCR-06-1150
In Vivo Validations
Mouse
Dose: 10-100 mg/kg
Route of delivery:
Oral
Organ of interest (O):
xenograft
Target engagement assay:
Indirect: inhibition of substrate phosphorylation in xenograft tissue
DOI Reference: 10.1158/1078-0432.CCR-06-1150
Chemical Information
| Molecular Formula | C17H15BrClFN4O3 |
| SMILEs | Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21 |
| InChI | InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) |
| Molecular weight | 456.00 Da |
| AlogP | 3.5256000000000016 |
| HBond acceptors | 7 |
| HBond donors | 3 |
| Atoms | 42 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.